Daily BriefsMost Read

Most Read: ICICI Bank Ltd, Dian Swastatika Sentosa, Chroma Ate Inc, Groww, Bio-Thera Solutions Ltd, Softcare, LG Chem Ltd, Binjiang Service Group, Nidec Corp and more

In today’s briefing:

  • NIFTY Bank Index: Methodology Changes to Result in Big Flows
  • IDX30/​​LQ45/IDX80 Index Rebalance: Plenty of Change with 4 Days to Trade
  • Chroma Ate (2360 TT): Double Index Inclusion Coming Up with Plenty to Buy
  • Groww IPO: Growwing Fast; Index Inclusions Will Be Sloww; Small Floww
  • Quiddity Leaderboard STAR 50/100 Dec25: Final Expectations; New Ideas
  • Softcare Pre-IPO: Decent Cornerstones, Riding on Africa Growth
  • LG Chem: Considering Higher Dividend Payout Using Sale Proceeds from LGES
  • Primer: Binjiang Service Group (3316 HK) – Nov 2025
  • STAR50 Index Earning Revision (Oct): SUPCON TECHNOLOGY, SHENGYI ELECTRONICS, TRANSSION, TRINA SOLAR
  • Last Week In Event SPACE: Nidec/Ibiden, LG Chem, Mayne Pharma, Jardine Matheson


NIFTY Bank Index: Methodology Changes to Result in Big Flows

By Brian Freitas

  • In May, SEBI recommended changes to the minimum number of constituents for non-benchmark indices and the capping for those indices. Then came the market consultation in August.
  • SEBI has now confirmed the changes along with the timeline for capping changes to the largest stocks in the index.
  • The changes could commence in December and continue till March. The adds will take place in December and weight changes for the largest stocks will take place in 4 tranches.

IDX30/​​LQ45/IDX80 Index Rebalance: Plenty of Change with 4 Days to Trade

By Brian Freitas


Chroma Ate (2360 TT): Double Index Inclusion Coming Up with Plenty to Buy

By Brian Freitas

  • A massive rally in Chroma Ate Inc (2360 TT) should see the stock added to a global index in November and then to another country ETF in December.
  • With one exception, Chroma Ate Inc (2360 TT) has outperformed its peers over the last 6 months. With large buying to come, that could continue in the short-term.
  • There is positioning in Chroma Ate Inc (2360 TT) and its peers. With continued momentum in the stock, the path of least resistance is higher.

Groww IPO: Growwing Fast; Index Inclusions Will Be Sloww; Small Floww

By Brian Freitas

  • Groww (1573648D IN) is looking to list on the exchanges by selling 663.23m shares via a primary and secondary offering to raise US$752m at a valuation of US$7bn.
  • The price band has been set at INR 95-100/share, and the issue is likely to price at the top end of the range.
  • The stock will not get Fast Entry to global indices. Inclusion at regular rebalances will commence in June 2026 but flow will be small given the low float.

Quiddity Leaderboard STAR 50/100 Dec25: Final Expectations; New Ideas

By Janaghan Jeyakumar, CFA

  • STAR 50 Index is a tech-focused, blue-chip index in Mainland China which tracks the top 50 largest and most liquid names in the STAR market of the Shanghai Stock Exchange.
  • STAR 100 index tracks the next 100 names (51st-150th ranks) and it represents the mid-cap segment of the STAR market.
  • In this insight, we have presented our final expectations for ADDs and DELs for the upcoming December 2025 index rebal event.

Softcare Pre-IPO: Decent Cornerstones, Riding on Africa Growth

By Nicholas Tan

  • Softcare (SOFT HK) is looking to raise up to US$307m in its upcoming Hong Kong IPO.
  • It is an international hygiene product corporation with a focus on fast-growing Emerging Markets including Africa, Latin America and Central Asia. 
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

LG Chem: Considering Higher Dividend Payout Using Sale Proceeds from LGES

By Douglas Kim

  • LG Chem is considering on paying higher dividends using sale proceeds from LG Energy Solution. 
  • This breaks the company’s principle of using only ordinary income from operating activities as a source for dividends.
  • If indeed LG Chem goes ahead with this plan, this would be as a result of heightened demands from major activist investors including Palliser Capital.

Primer: Binjiang Service Group (3316 HK) – Nov 2025

By αSK

  • Binjiang Service is a high-growth property management firm with a strong brand in the premium segment of the Yangtze River Delta, benefiting from the stable pipeline of its reputable parent developer, Binjiang Real Estate.
  • The company is strategically shifting its focus towards high-margin ‘5S’ value-added services (VAS), particularly in soft decoration and community living, to offset declining revenues and margins in its non-owner VAS segment.
  • While demonstrating robust top-line growth and a generous dividend policy, the company faces significant risks from the broader downturn in China’s property market, intense industry competition, and rising operational costs.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


STAR50 Index Earning Revision (Oct): SUPCON TECHNOLOGY, SHENGYI ELECTRONICS, TRANSSION, TRINA SOLAR

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of STAR50 in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on SUPCON TECHNOLOGY, SHENGYI ELECTRONICS, TRANSSION, TRINA SOLAR, CAMBRICON TECHNOLOGIES, Trina Solar, Shengyi Electronics, Cambricon Technologies, Transsion, Supcon Technology.

Last Week In Event SPACE: Nidec/Ibiden, LG Chem, Mayne Pharma, Jardine Matheson

By David Blennerhassett

  • Nidec (6594 JP)‘s deletion is a LOT of stock to sell. The Ibiden (4062 JP)‘s Nikkei 225 inclusion is huge. It’ll make the stock enormously squeezy for a long while.
  • Palliser has a point. LG Chem (051910 KS) should pare down its LG Energy Solution (373220 KS) stake, and buy back shares. Yet, would/will management stubbornly swat away any such proposal?
  • The latest twist in the Mayne Pharma (MYX AU) saga as FIRB looks set to ding the transaction if there is a possibility Cosette closes a manufacturing site in Adelaide.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars